Drug Discovery · Jersey City, NJ · Founded 2018 · Privately Held (backing)
Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. Claris Bio is based in Jersey City, NJ and was founded in 2018. It was valued at $163 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $54.5 million Series A in Jan 2024.
PMV mark · valuation
$163.4M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$153.6M
Last round
Later Stage VC (Series A)
Jan 2024
Team — not yet on record
No current team members for Claris Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Claris Bio with a free account
·Watch Claris Bio: the Monday email on marks, rounds and moves
